Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every contract, funding round, exec hire, and M&A move on GENESIS Pharma — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

GENESIS Pharma and Otsuka Pharmaceutical Europe Ltd. form a partnership to commercialize donidalorsen for hereditary angioedema in Central and Eastern Europe.

Dec 15, 2025•5 months ago

Contract Type

partnership

AthensBiotechnologyHealth CarePharmaceutical

Description

GENESIS Pharma has announced an exclusive partnership with Otsuka Pharmaceutical Europe Ltd. to distribute donidalorsen in fourteen European markets. This collaboration aims to combat hereditary angioedema and expand access to innovative treatments in the region.

Company Information

Company

GENESIS Pharma

Location

Athens, Attica, Greece

About

GENESIS Pharma is a regional biopharma company dedicated to the commercialization of innovative medicines in Central and Eastern Europe. The company focuses on addressing health needs in the region with effective treatment solutions. Their portfolio includes various therapeutic areas and aims to improve patient outcomes.

Predictive Intelligence
Strategic

ML-powered predictions for GENESIS Pharma's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months